ABBV vs EBS
AbbVie Inc (ABBV) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. EBS currently screens at market cap $416.4M.
Not investment advice. Open the ABBV and EBS stock pages for the full models.
Not investment advice.